The clinical characteristics and prognosis of patients with SAPHO syndrome--a real-world cohort study

被引:4
|
作者
Duan, Hongji [1 ]
Gao, Shuang [2 ]
Zhang, Lihua [3 ]
Song, Le [4 ]
Zhai, Jiayu [5 ]
Deng, Xiaoli [1 ]
机构
[1] Capital Med Univ, Beijing Jishuitan Hosp, Dept Orthoped Med, 31 Xinjiekou East St, Beijing 100035, Peoples R China
[2] Peking Univ Third Hosp, Lymphoma Ctr, Dept Hematol, Beijing, Peoples R China
[3] Peking Univ Third Hosp, Dept Radiol, Beijing, Peoples R China
[4] Peking Univ Third Hosp, Dept Nucl Med, Beijing, Peoples R China
[5] Peking Univ Third Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China
关键词
Iguratimod; Outcome; SAPHO syndrome; Treatment; NF-KAPPA-B; OSTEITIS SAPHO; SINGLE-CENTER; HYPEROSTOSIS; PUSTULOSIS; ACNE; SYNOVITIS; CELLS; T-614; BONE;
D O I
10.1007/s10067-023-06782-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesWe aimed to analyze the clinical characteristics and outcomes of patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.MethodsThe clinical records of 64 patients with SAPHO syndrome were collected, and the treatment and outcomes of 27 patients were followed up. The patients were divided into three groups according to the site of bone lesions: only anterior chest wall (ACW) involvement, only spinal involvement, and bone lesion involvement at both sites. The clinical characteristics and outcomes were compared. The clinical characteristics of the patients with and without peripheral joint involvement were compared.ResultsAmong all patients, 31.25% (20/64) had only ACW involvement, 15.63% (10/64) had only spinal involvement, and 53.12% (34/64) had both ACW and spinal involvement. Peripheral joint involvement was observed in 25.00% (16/64) of the patients. Patients with only spinal involvement were older than those with only ACW involvement (p = 0.006). Patients with both ACW and spinal involvement were older than those with only ACW involvement (p = 0.002) and had a longer diagnosis delay (p = 0.015). Patients with peripheral joint involvement were younger than those without peripheral joint involvement (p = 0.028). During follow-up, 88.89% (24/27) of patients had good outcomes. Twenty-two patients were treated with non-steroidal anti-inflammatory drugs + Iguratimod (IGU), and the outcomes of 90.91% (20/22) improved.ConclusionsA relationship may exist between the sites of bone lesions and clinical characteristics of patients with SAPHO syndrome. The clinical outcomes of these patients may be good, and IGU may be effective in treating SAPHO syndrome.Key Points center dot This study is the first long-term follow-up on the effectiveness of iguratimod in treating patients with SAPHO.center dot This study revealed that patients with SAPHO and different bone lesion sites may present with different clinical characteristics.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 50 条
  • [1] The clinical characteristics and prognosis of patients with SAPHO syndrome——a real-world cohort study
    Hongji Duan
    Shuang Gao
    Lihua Zhang
    Le Song
    Jiayu Zhai
    Xiaoli Deng
    Clinical Rheumatology, 2024, 43 : 561 - 568
  • [2] Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study
    Hashimoto, Shu
    Yoshida, Yuri
    Makita, Naoyuki
    Sorimachi, Ryoko
    Sugaya, Satoko
    Arita, Yoshifumi
    Hayashi, Nobuya
    Tashiro, Naoki
    Ichinose, Masakazu
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 37 - 46
  • [3] A real-world study of Alemtuzumab in a cohort of Italian patients
    Sacca, F.
    Russo, C. V.
    Frau, J.
    Annovazzi, P.
    Signoriello, E.
    Bonavita, S.
    Grasso, R.
    Clerico, M.
    Cordioli, C.
    Laroni, A.
    Capobianco, M.
    Clerici, V. Torri
    Sartori, A.
    Cavalla, P.
    Maniscalco, G. T.
    La Gioia, S.
    Caleri, F.
    Giugno, A.
    Iodice, R.
    Carotenuto, A.
    Cocco, E.
    Fenu, G.
    Zaffaroni, M.
    Baronicini, D.
    Lus, G.
    Gallo, A.
    De Mercanti, S. F.
    Lapucci, C.
    Di Francescantonio, V.
    Sormani, M. P.
    Signori, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 796 - 797
  • [4] A real-world study of alemtuzumab in a cohort of Italian patients
    Russo, Cinzia Valeria
    Sacca, Francesco
    Frau, Jessica
    Annovazzi, Pietro
    Signoriello, Elisabetta
    Bonavita, Simona
    Grasso, Roberta
    Clerico, Marinella
    Cordioli, Cinzia
    Laroni, Alice
    Capobianco, Marco
    Clerici, Valentina Torri
    Sartori, Arianna
    Cavalla, Paola
    Maniscalco, Giorgia Teresa
    La Gioia, Sara
    Caleri, Francesca
    Giugno, Alessia
    Iodice, Rosa
    Carotenuto, Antonio
    Cocco, Eleonora
    Fenu, Giuseppe
    Zaffaroni, Mauro
    Baroncini, Damiano
    Lus, Giacomo
    Gallo, Antonio
    De Mercanti, Stefania Federica
    Lapucci, Caterina
    Di Francescantonio, Valeria
    Brambilla, Laura
    Sormani, Maria Pia
    Signori, Alessio
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (01) : 257 - 266
  • [5] Clinical characteristics, imaging diagnostic accuracy, and prognosis of autoimmune pancreatitis: A real-world study in China
    Liu, Yue
    Wan, Dong Ling
    Yang, Zheng Hui
    Liu, Chao
    Tu, Ya Tao
    Liu, Yu Ting
    Wang, Xin Yue
    Xu, Jia Beng
    Jiang, Meng Ruo
    Zhang, De Yu
    Wu, Chang
    Jin, Zhen Dong
    Li, Zhao Shen
    Sun, Li Qi
    Huang, Hao Jie
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (9-10) : 615 - 623
  • [6] Clinical characteristics and prognosis of liver injury induced by immune checkpoint inhibitors in patients with malignancies: A real-world retrospective study
    Jiang, Ying
    Lv, Minzhi
    Jin, Zhiping
    Wu, Yi
    Li, Xiaoyu
    Zhang, Ningping
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (11) : 2870 - 2882
  • [7] THE CLINICAL FEATURES OF SAPHO SYNDROME IN JAPANESE PATIENTS: A SINGLE CENTER COHORT STUDY
    Akiyama, Y.
    Sato, T.
    Hanai, S.
    Kamata, Y.
    Nagatani, K.
    Iwamoto, M.
    Okazaki, H.
    Minota, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 756 - 756
  • [8] COMPARISON OF PARTICIPANT CHARACTERISTICS IN THE REAL-WORLD OBSERVATIONAL CONTOR STUDY WITH THOSE IN RANDOMIZED CLINICAL TRIALS (RCT): ARE REAL-WORLD PATIENTS LIKE CLINICAL TRIAL PATIENTS?
    Fu, A.
    Abel, J. L.
    Reasner, D. S.
    Carson, R. T.
    Martin, C.
    Hunter, Goolsby A.
    Buzinec, P.
    Essoi, B.
    Taylor, D. C.
    VALUE IN HEALTH, 2017, 20 (05) : A185 - A186
  • [9] Optyx study: Clinical characteristics and preferences for initiating relugolix in a cohort of US patients in real-world care settings.
    Spratt, Daniel Eidelberg
    McKay, Rana R.
    Ross, Ashley
    Lowentritt, Benjamin H.
    Flanders, Scott C.
    Zhong, Yi
    Hong, Agnes
    Ryan, Michael
    Dorff, Tanya B.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [10] Real-World Characteristics and Clinical Outcomes of European Patients With Hypereosinophilic Syndrome Receiving Biologics in Europe
    Baylis, Lee
    Hwee, Jeremiah
    Huynh, Lynn
    Alfonso-Cristancho, Rafael
    Khanal, Anamika
    Duh, Mei Sheng
    Rothenberg, Marc
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB216 - AB216